Following the 2018 release of the CDC’s Opioid Guidelines, pharmacists and other healthcare professionals have become increasingly involved in the identification and management of substance use disorders. However, the wording of the guidelines has created ambiguity around the appropriateness of opioid use. Improving understanding of chronic opioid therapy will allow pharmacists and other healthcare professionals to partner with providers to ensure regimens are safe and effective.

This CPE activity will focus on presenting guidelines as a “guideline” rather than a black and white application for all patients. Areas of ambiguity such as MED cut-offs will be addressed. Tools to help determine the safety and efficacy of therapy will be introduced. The relationship between mental health conditions and opioid use will also be discussed.

At the conclusion of this continuing education activity, the participant will be able to:

1.  Identify how Key Recommendations from the Center for Disease Control and Prevention 2016 Guidelines on Chronic Opioid Use for Non-Cancer Pain can be applied to patient care scenarios
2. Recognize the differences between opioid dependence and opioid addiction
3. Describe the basics of opioid tapering

At the conclusion of this continuing education activity, the participant will be able to:

1.  Review the Key Recommendations from Center for Disease Control and Prevention 2016 Guidelines on Chronic Opioid Use for Non-Cancer Pain
2. Identify medications that are classified as opioids
3. Recognize the differences between opioid dependence and opioid addiction

At the conclusion of this continuing education activity, the participant will be able to:

1.  Review the Key Recommendations from Center for Disease Control and Prevention 2016 Guidelines on Chronic Opioid Use for Non-Cancer Pain
2. Identify medications that are classified as opioids
3. Recognize the differences between opioid dependence and opioid addiction

AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-799357.

AchieveCE is an approved provider of nursing continuing professional development by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. GNA Approved Provider Number is 4003268.

AchieveCE is accredited through the Academy of General Dentistry (AGD) with provider ID #386503.

Jineane Venci, PharmD, BCACP received her Doctorate of Pharmacy from the University at Buffalo School of Pharmacy and PharmaceuticalSciences and a Master of Science in Clinical Investigation from the University of Rochester. She completed a PGY1residency and is board certified in ambulatory pharmacotherapy. She has no actual or potential conflicts of interest to disclose.

  Level 2. Basic Application of Skills and Concepts